Free shipping on all orders over $ 500

IMT1

Cat. No. M11519

All AbMole products are for research use only, cannot be used for human consumption.

IMT1  Structure
Size Price Availability Quantity
5mg USD 220 In stock
10mg USD 385 In stock
25mg USD 700 In stock
50mg USD 1000 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

IMT1 is the first, specific and non-competitive inhibitor of human mitochondrial RNA polymerase (POLRMT). IMT1 induces conformational changes in POLRMT that block substrate binding and transcription in a dose-dependent manner in vitro. IMT1 reduced deoxynucleoside triphosphate levels and citric acid cycle intermediates, resulting in significant depletion of cellular amino acid levels. IMT1 has the potential to be used in the study of mitochondrial transcription and other related diseases.

Chemical Information
Molecular Weight 351.4
Formula C21H21NO4
CAS Number 2304621-31-4
Form Solid
Solubility (25°C) DMSO ≥ 40 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Mara Mennuni, et al. EMBO Rep. Metabolic resistance to the inhibition of mitochondrial transcription revealed by CRISPR-Cas9 screen

[2] Cheng-Hsun Li, et al. Physiol Plant. Myo-inositol transport and metabolism participate in salt tolerance of halophyte ice plant seedlings

[3] Lauren Passby. Med Teach. Melanin matters: Ethnic diversity in dermatology textbooks

[4] Miki Oike, et al. Obes Res Clin Pract. Association between abdominal fat distribution and atherosclerotic changes in the carotid artery

[5] G Rammesmayer, et al. Arch Biochem Biophys. Characterization of IMT1, myo-inositol O-methyltransferase, from Mesembryanthemum crystallinum

Related Mitochondrial Related Products
Thiabendazole

Thiabendazole inhibites the mitochondrial helminth-specific enzyme, fumarate reductase, with anthelminthic property.

VLX600

VLX600 is a novel inhibitor of iron-chelated oxidative phosphorylation (OXPHOS). VLX600 causes mitochondrial dysfunction and can show enhanced cytotoxicity in nutrient deficiency conditions. VLX600 showed selective cytotoxic activity against malignant cells and induced autophagy and had anticancer activity.*The compound is unstable in solutions, freshly prepared is recommended

FCCP

FCCP is a mitochondrial uncoupling agent and an oxidative phosphorylation (OXPHOS) inhibitor. FCCP is often used as an apoptosis inducer.

Lixumistat

Lixumistat (IM156) is a novel biguanide mitochondrial protein complex 1 inhibitor of oxidative phosphorylation (OXPHOS) with anti-tumor activity. Lixumistat regulates OXPHOS to attenuate mitochondrial metabolic reprogramming and inhibit lung fibrosis. Lixumistat (IM156) is a metformin derivative, which increases AMPK phosphorylation.

KL1333

KL1333 is an orally available, small organic molecule that reacts with NAD(P)H:quinone oxidoreductase 1 (NQO1) as a substrate, resulting in increases in intracellular NAD+ levels via NADH oxidation.

  Catalog
Abmole Inhibitor Catalog




Keywords: IMT1 supplier, Mitochondrial Related, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.